Company Filing History:
Years Active: 2014-2016
Title: Galina Rodionov: Innovator in Tumor Treatment
Introduction
Galina Rodionov is a notable inventor based in Yavne, Israel, recognized for her contributions to the field of tumor treatment. With a focus on developing innovative therapies, she has secured 2 patents that aim to enhance the survival of patients with tumors.
Latest Patents
Rodionov's latest patents include groundbreaking methods for utilizing monoclonal antibodies in tumor treatment. One patent describes a method that involves administering a humanized monoclonal antibody or a fragment thereof, which contains complementarity determining regions from the murine monoclonal antibody BAT (mBAT-1) along with a framework region from an acceptor human immunoglobulin. This method is designed to be administered in conjunction with chemotherapeutic agents such as 5-fluorouracil, cytarabine, oxaliplatin, and paclitaxel, either simultaneously or within a specific timeframe after chemotherapy. The second patent focuses on methods for inhibiting tumor growth and increasing survival rates in subjects with tumors by administering a humanized monoclonal antibody derived from mBAT-1, combined with at least one chemotherapeutic agent.
Career Highlights
Galina Rodionov has made significant strides in her career, particularly through her work at Curetech Ltd. Her innovative approaches to cancer treatment have positioned her as a key figure in the biotechnology sector.
Collaborations
Rodionov collaborates with Rinat Rotem-Yehudar, who is also involved in the development of advanced therapeutic methods. Their partnership exemplifies the collaborative spirit in the field of medical research.
Conclusion
Galina Rodionov's work in developing monoclonal antibodies for tumor treatment showcases her dedication to improving patient outcomes. Her innovative patents and collaborations highlight her significant contributions to the field of oncology.